C109H130F12N34O10S5 — CID 161253435
3-[4-[1-(3-aminocyclopentyl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-[4-(aminomethyl)cyclohexyl]piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-(7-azabicyclo[2.2.1]heptan-2-yl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-[4-(1-piperidin-4-ylpiperidin-4-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide (PubChem CID 161253435) has the molecular formula C109H130F12N34O10S5 and a molecular weight of 2464.78 g/mol. Its IUPAC name is 3-[4-[1-(3-aminocyclopentyl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-[4-(aminomethyl)cyclohexyl]piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-(7-azabicyclo[2.2.1]heptan-2-yl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-[4-(1-piperidin-4-ylpiperidin-4-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide.
| Compound Name | 3-[4-[1-(3-aminocyclopentyl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-[4-(aminomethyl)cyclohexyl]piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-(7-azabicyclo[2.2.1]heptan-2-yl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-[4-(1-piperidin-4-ylpiperidin-4-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide |
|---|---|
| PubChem CID | 161253435 |
| Molecular Formula | C109H130F12N34O10S5 |
| Molecular Weight | 2464.78 g/mol |
| Exact Mass | 2462.91 |
| IUPAC Name | 3-[4-[1-(3-aminocyclopentyl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-[4-(aminomethyl)cyclohexyl]piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[1-(7-azabicyclo[2.2.1]heptan-2-yl)piperidin-4-yl]phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(dimethylamino)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;3-[4-(1-piperidin-4-ylpiperidin-4-yl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide |
| SMILES | Cc1ccc(N(C)C)c(-c2nn[nH]n2)c1S(N)(=O)=O.NC1CCC(N2CCC(c3ccc(-c4ccc(C(F)(F)F)c(S(N)(=O)=O)c4-c4nn[nH]n4)cc3)CC2)C1.NCC1CCC(N2CCC(c3ccc(-c4ccc(C(F)(F)F)c(S(N)(=O)=O)c4-c4nn[nH]n4)cc3)CC2)CC1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCN(C4CC5CCC4N5)CC3)cc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCN(C4CCNCC4)CC3)cc2)c1-c1nn[nH]n1 |
| InChI | InChI=1S/C26H32F3N7O2S.C25H28F3N7O2S.2C24H28F3N7O2S.C10H14N6O2S/c27-26(28,29)22-10-9-21(23(24(22)39(31,37)38)25-32-34-35-33-25)19-5-3-17(4-6-19)18-11-13-36(14-12-18)20-7-1-16(15-30)2-8-20;26-25(27,28)19-7-6-18(22(23(19)38(29,36)37)24-31-33-34-32-24)16-3-1-14(2-4-16)15-9-11-35(12-10-15)21-13-17-5-8-20(21)30-17;25-24(26,27)20-6-5-19(21(22(20)37(28,35)36)23-30-32-33-31-23)17-3-1-15(2-4-17)16-9-13-34(14-10-16)18-7-11-29-12-8-18;25-24(26,27)20-8-7-19(21(22(20)37(29,35)36)23-30-32-33-31-23)16-3-1-14(2-4-16)15-9-11-34(12-10-15)18-6-5-17(28)13-18;1-6-4-5-7(16(2)3)8(9(6)19(11,17)18)10-12-14-15-13-10/h3-6,9-10,16,18,20H,1-2,7-8,11-15,30H2,(H2,31,37,38)(H,32,33,34,35);1-4,6-7,15,17,20-21,30H,5,8-13H2,(H2,29,36,37)(H,31,32,33,34);1-6,16,18,29H,7-14H2,(H2,28,35,36)(H,30,31,32,33);1-4,7-8,15,17-18H,5-6,9-13,28H2,(H2,29,35,36)(H,30,31,32,33);4-5H,1-3H3,(H2,11,17,18)(H,12,13,14,15) |
| InChIKey | VBORNGPCVALMJC-UHFFFAOYSA-N |
| XLogP | 13.45 |
| TPSA | 665.40 Ų |
| H-Bond Donors | 14 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 170 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2464.78 |
| LogP ≤ 5 | 13.45 |
| H-Bond Donors ≤ 5 | 14 |
| H-Bond Acceptors ≤ 10 | 34 |